ALLMedicine™ Cardiogenic Pulmonary Edema Center

Oct 4th, 2022 - Dynamic analysis of blood components is of great importance in understanding cardiovascular diseases and their related diseases, such as myocardial infarction, arrhythmia, atherosclerosis, cardiogenic pulmonary edema, pulmonary embolism, and cereb...

Jul 23rd, 2022 - To determine the diagnostic accuracy of lung ultrasound signs for both the diagnosis of interstitial syndrome and for the discrimination of noncardiogenic interstitial syndrome (NCIS) from cardiogenic pulmonary edema (CPE) in a mixed ICU populatio...

Jul 20th, 2022 - Noninvasive respiratory support (NRS) has been used to treat acute respiratory failure outside the ICU, but existing data have left many knowledge gaps for managing NRS in general wards. The primary objective of this study was to describe indicati...

Jul 6th, 2022 - Heart rate, acidosis, consciousness, oxygenation, and respiratory rate (HACOR) have been used to predict noninvasive ventilation (NIV) failure. However, the HACOR score fails to consider baseline data. Here, we aimed to update the HACOR score to t...

Jun 19th, 2022 - Peri-intubation cardiac arrest is an uncommon, serious complication following endotracheal intubation in the emergency department. Although several risk factors have been previously identified, this study aimed to comprehensively identify risk fac...

Jun 3rd, 2022 - It was a retrospective observational study performed in a internal medicine ward of a French University Hospital. Patients were identified in the hospital database, pertinent features and eFoCUS findings were extracted and anonymized. Inclusion cr...

Feb 18th, 2022 - Half of the patients undergoing mechanical ventilation in intensive care have moderate to severe dyspnea. This dyspnea has a negative impact on the prognosis and quality of life in the medium term. As ECMOs, techniques for extracorporeal assistanc...

Nov 16th, 2021 - Project Focus The focus of this project is to improve the ventilatory management of patients with acute respiratory failure in the critical care setting by enhancing the use of non-invasive ventilation, a goal that should lead to improved outcomes...

Aug 10th, 2021 - Dyspnea and acute respiratory failure are among the top 5 reasons for patients to present to the emergency department (ED)(1).Supplemental oxygen therapy forms the cornerstone of resuscitation of the acutely unwell patient.Under normal circumstanc...

Apr 1st, 2021 - Mechanical ventilation is the cornerstone of the critically-ill patients support, providing better gas exchange conditions while respiratory muscles rest. Providing this life-support technique may be harmful on the lung tissue, last decades resear...

Sep 29th, 2022 - Aumolertinib significantly prolonged progression-free survival (PFS) vs gefitinib (Iressa) in treatment-naïve patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) harboring EGFR mutations, according to findings from the ...

Feb 1st, 2019 - The early use of norepinephrine in patients with septic shock was associated with increased shock control within 6 hours of diagnosis in a randomized, placebo-controlled trial conducted in Thailand. Patients treated with early norepinephrine in th...

Feb 1st, 2019 - The early use of norepinephrine in patients with septic shock was associated with increased shock control within 6 hours of diagnosis in a randomized, placebo-controlled trial conducted in Thailand. Patients treated with early norepinephrine in th...

Nov 30th, 2018 - The Food and Drug Administration has issued a safety communication warning that cases of differentiation syndrome are going unnoticed in patients treated with the IDH2 inhibitor enasidenib (Idhifa). Enasidenib is FDA approved to treat adults with.

Nov 30th, 2018 - Photo from Business Wire Enasidenib (Idhifa®) The U. S.